Disparities in the access to immune checkpoint inhibitors approved in the United States, the European Union and mainland China: a serial cross-sectional study

Disparities in the access to immune checkpoint inhibitors approved in the United States, the European Union and mainland China: a serial cross-sectional study

Background Immune checkpoint inhibitors (ICIs) have revolutionised antitumour therapy. However, regional differences in ICI labels, including the impact of the review process and supporting trial evidence, remain unclear.Methods We conducted a serial cross-sectional study to examine trends and diffe...

Full description

Saved in:
Bibliographic Details
Main Authors: Jin-Ling Tang, Hao Hu, Carolina Oi Lam Ung, Shi-Yu Wang, Jia-Xin Cai, Fu-Xiao Li, Teng-Fei Lin, Shi-Fu Luo, Hai-Bo Song, Zhi-Rong Yang, Wei-Hua Meng
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Public Health
Online Access:https://bmjpublichealth.bmj.com/content/3/1/e001995.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items